Business Standard

HC seeks Singh brothers' reply on Daiichi's plea to sell Fortis trademark

Senior advocate Arvind Nigam, appearing for Daiichi, said this was a deliberate attempt to deprive the company from enjoying the fruits of the award in its favour

IHH Healthcare makes open offer for Fortis Malar at Rs 60 per share
Premium

The high court has directed for maintaining status quo on the Religare trademark till July 28

Press Trust of India New Delhi
The Delhi High Court has sought response of former Ranbaxy promoters Malvinder Mohan Singh and Shivinder Mohan Singh on a plea by Daiichi Sankyo seeking to attach and sell trademarks of Fortis and Religare and recover the amount due to the Japanese company.

The high court has directed for maintaining status quo on the Religare trademark till July 28.

The high court has been hearing the petition filed by Japanese pharma major Daiichi Sankyo seeking execution of Rs 3,500 crore Singapore tribunal arbitral award passed in its favour and against the Singh brothers, former promoters of Fortis Healthcare, in April

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 25 2020 | 3:47 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com